Caxton Associates (New York)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $23.3M | Buy |
+300,000
| New | +$23.3M | 0.73% | 21 |
|
|
2022
Q1 | – | Sell |
-10,140
| Closed | -$1.36M | – | 531 |
|
|
2021
Q4 | $1.36M | Buy |
+10,140
| New | +$1.36M | 0.14% | 54 |
|
|
2020
Q4 | – | Sell |
-3,840
| Closed | -$396K | – | 161 |
|
|
2020
Q3 | $396K | Buy |
+3,840
| New | +$396K | 0.04% | 132 |
|
|
2020
Q2 | – | Sell |
-8,020
| Closed | -$540K | – | 490 |
|
|
2020
Q1 | $540K | Buy |
+8,020
| New | +$540K | 0.1% | 142 |
|